New CVS and Express Scripts Value Based Plans for Oncology

CVS and Express Scripts recently announced new plans to determine price and access to cancer drugs based on value. Learn more about these plans and others, such as Memorial Sloan Kettering’s Drug Abacus here. (Source: Tracey Walker, 4/3/16)

You might also be interested in:

Tufts Analyzes Cost-Effectiveness Analysis for 1974-2018 07/28/2020
Robert Dubois, MD, PhD, Steps in as Interim President and CEO… 09/01/2020
Patient Drug Costs Increased as Health Plans Promote… 08/07/2020
What Are The Recent Top 4 Innovative Consolidations and… 08/26/2020
Data Exchange for Drug Rebate Processing and Contract… 08/31/2020
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
Association for Accessible Medicines (AAM) Names Health Care… 08/25/2020